
Correction to: Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial
2021; Springer Science+Business Media; Volume: 58; Issue: 4 Linguagem: Inglês
10.1007/s00592-021-01689-8
ISSN1432-5233
AutoresFlávio Danni Fuchs, Luiz César Nazário Scala, José Fernando Vilela-Martin, Paul K. Whelton, Carlos Eduardo Poli‐de‐Figueiredo, Ricardo Pereira e Silva, Miguel Gus, Luiz Aparecido Bortolotto, Fernanda Marciano Consolim‐Colombo, Rosane Paixão Schlatter, Evandro José Cesarino, Iran Castro, José Albuquerque de Figueiredo Neto, Hilton Chaves, André Avelino Steffens, João Guilherme Bezerra Alves, Andréa Araújo Brandão, Marcos Roberto de Sousa, Paulo César Brandão Veiga Jardim, Leila Beltrami Moreira, Roberto Silva Franco, Marco M. Gomes, Abrahão Afiune Neto, Felipe Costa Fuchs, Dário Celestino Sobral Filho, Antônio Cláudio Lucas da Nóbrega, Fernando Nobre, Otávio Berwanger, Sandra Cristina Pereira Costa Fuchs,
Tópico(s)Blood Pressure and Hypertension Studies
ResumoA correction to this paper has been published: https://doi.org/10.1007/s00592-021-01689-8.
Referência(s)